PortfoliosLab logoPortfoliosLab logo
PSCH vs. XPH
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PSCH vs. XPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco S&P SmallCap Health Care ETF (PSCH) and SPDR S&P Pharmaceuticals ETF (XPH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

The year-to-date returns for both investments are quite close, with PSCH having a 21.97% return and XPH slightly higher at 22.08%. Over the past 10 years, PSCH has outperformed XPH with an annualized return of 8.26%, while XPH has yielded a comparatively lower 4.80% annualized return.


PSCH

1D
0.65%
1M
-0.09%
6M
20.27%
YTD
21.97%
1Y
41.37%
3Y*
7.41%
5Y*
-2.71%
10Y*
8.26%
ALL TIME*
12.50%

XPH

1D
0.25%
1M
1.59%
6M
19.87%
YTD
22.08%
1Y
64.62%
3Y*
17.93%
5Y*
7.45%
10Y*
4.80%
ALL TIME*
9.39%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.89M$1.58M$1.08M
$7.06M$7.70M$5.53M

PSCH vs. XPH - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PSCH
Invesco S&P SmallCap Health Care ETF
21.97%-0.49%3.77%-2.71%-25.15%5.75%31.47%20.17%9.15%34.87%
XPH
SPDR S&P Pharmaceuticals ETF
22.08%31.60%4.94%2.97%-9.83%-10.54%14.68%25.61%-15.32%12.05%

Correlation

The correlation between PSCH and XPH is 0.73, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.73

Correlation (3Y)
Balances recent behavior with more history.

0.76

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.79

Correlation (10Y)
Provides a long-term view across more market conditions.

0.78

Correlation (All Time)
Calculated using the full available price history since Apr 7, 2010

0.79

The correlation between PSCH and XPH has been stable across timeframes, ranging from 0.73 to 0.79 - a consistent structural relationship.

PSCH vs. XPH - Sectors Allocation Comparison


Sectors
PSCH
XPH

Healthcare

97.4%
100.0%

Technology

1.0%

-

Financial Services

0.9%

-

Industrials

0.7%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Real Estate

-

-

Utilities

-

-

Healthcare

PSCH
97.4%
XPH
100.0%

Technology

PSCH
1.0%
XPH

-

Financial Services

PSCH
0.9%
XPH

-

Industrials

PSCH
0.7%
XPH

-

Basic Materials

PSCH

-

XPH

-

Communication Services

PSCH

-

XPH

-

Consumer Cyclical

PSCH

-

XPH

-

Consumer Defensive

PSCH

-

XPH

-

Energy

PSCH

-

XPH

-

Real Estate

PSCH

-

XPH

-

Utilities

PSCH

-

XPH

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PSCH vs. XPH — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

PSCH
PSCH Risk / Return Rank: 7878
Overall Rank
PSCH Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
PSCH Sortino Ratio Rank: 8585
Sortino Ratio Rank
PSCH Omega Ratio Rank: 8080
Omega Ratio Rank
PSCH Calmar Ratio Rank: 7373
Calmar Ratio Rank
PSCH Martin Ratio Rank: 6868
Martin Ratio Rank

XPH
XPH Risk / Return Rank: 9494
Overall Rank
XPH Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
XPH Sortino Ratio Rank: 9494
Sortino Ratio Rank
XPH Omega Ratio Rank: 9292
Omega Ratio Rank
XPH Calmar Ratio Rank: 9595
Calmar Ratio Rank
XPH Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

PSCH vs. XPH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco S&P SmallCap Health Care ETF (PSCH) and SPDR S&P Pharmaceuticals ETF (XPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PSCHXPHDifference
Sharpe ratioReturn per unit of total volatility

-0.81

Sortino ratioReturn per unit of downside risk

-0.81

Omega ratioGain probability vs. loss probability

1.35

1.46

-0.10

Calmar ratioReturn relative to maximum drawdown

2.71

5.43

-2.72

Martin ratioReturn relative to average drawdown

8.67

19.31

-10.63

PSCH vs. XPH - Sharpe Ratio Comparison

The current PSCH Sharpe Ratio is 2.07, which is comparable to the XPH Sharpe Ratio of 2.88. The chart below compares the historical Sharpe Ratios of PSCH and XPH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PSCH vs. XPH - Drawdown Comparison

The maximum PSCH drawdown since its inception was -46.32%, roughly equal to the maximum XPH drawdown of -48.03%. Use the drawdown chart below to compare losses from any high point for PSCH and XPH.


Loading charts...

Drawdown Indicators


PSCHXPHDifference

Max Drawdown

Largest peak-to-trough decline

-46.32%

-48.03%

+1.71%

Max Drawdown (1Y)

Largest decline over 1 year

-15.36%

-11.97%

-3.39%

Max Drawdown (3Y)

Largest decline over 3 years

-22.98%

-23.57%

+0.59%

Max Drawdown (5Y)

Largest decline over 5 years

-45.37%

-30.92%

-14.45%

Max Drawdown (10Y)

Largest decline over 10 years

-46.32%

-35.97%

-10.35%

Current Drawdown

Current decline from peak

-16.84%

-2.60%

-14.24%

Average Drawdown

Average peak-to-trough decline

-13.52%

-17.12%

+3.60%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.78%

3.36%

+1.42%

Volatility

PSCH vs. XPH - Volatility Comparison

The current volatility for Invesco S&P SmallCap Health Care ETF (PSCH) is 4.74%, while SPDR S&P Pharmaceuticals ETF (XPH) has a volatility of 7.62%. This indicates that PSCH experiences smaller price fluctuations and is considered to be less risky than XPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PSCHXPHDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.74%

7.62%

-2.88%

Volatility (6M)

Calculated over the trailing 6-month period

14.66%

17.53%

-2.87%

Volatility (1Y)

Calculated over the trailing 1-year period

20.13%

22.59%

-2.46%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.95%

21.02%

+1.93%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.64%

22.14%

+1.50%

PSCH vs. XPH - Expense Ratio Comparison

PSCH has a 0.29% expense ratio, which is lower than XPH's 0.35% expense ratio.


Dividends

PSCH vs. XPH - Dividend Comparison

PSCH's dividend yield for the trailing twelve months is around 0.01%, less than XPH's 0.49% yield.


PositionTTM20252024202320222021202020192018201720162015
PSCH
Invesco S&P SmallCap Health Care ETF
0.01%0.04%0.27%0.01%2.27%0.00%0.00%0.00%0.00%0.00%0.03%0.00%
XPH
SPDR S&P Pharmaceuticals ETF
0.49%0.83%1.58%1.28%1.64%0.95%0.47%0.64%0.65%0.67%0.63%7.15%

Frequently Asked Questions


PSCH and XPH have a correlation of 0.73, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XPH has higher volatility (7.62%) compared to PSCH (4.74%). In terms of maximum drawdown, PSCH dropped -46.32% vs XPH's -48.03%.

On 10-year performance, PSCH leads with 8.26% vs 4.80% for XPH. On fees, PSCH is cheaper at 0.29% per year. On volatility, PSCH has been the lower-risk option at 4.74%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, PSCH has performed better with a 8.26% return vs 4.80%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

PSCH is cheaper with a 0.29% expense ratio, compared with 0.35% for XPH.

XPH has the higher dividend yield at 0.49%, compared with 0.01% for PSCH.

PSCH tracks S&P SmallCap 600 Health Care Index, while XPH tracks S&P Pharmaceuticals Select Industry Index. They also come from different issuers: Invesco and State Street. Their fees differ too: 0.29% for PSCH and 0.35% for XPH.

XPH currently has the higher Sharpe Ratio (2.88 vs 2.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PSCH and XPH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer